Product logins

Find logins to all Clarivate products below.


Breast Biopsy Devices | Medtech 360 | Market Analysis | Global | 2016

Moderate expansion of the global breast biopsy device market will be driven primarily by the increasing use of premium-priced VAB devices, as well as growth in procedure volumes resulting from women becoming more aware about the importance of breast cancer screening, especially in developing markets.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the breast biopsy device market in the US, Europe, and Asia Pacific region across a 10-year period.

Related Medtech Insights Reports

Report
Coronary Artery Bypass Graft Devices – Market Insights – United States
The US CABG device market will be supported by sustained demand for surgical revascularization in patients with increasingly complex CAD, where CABG remains the preferred treatment option…
Report
Diagnostic Imaging Systems – Market Insights – Japan
Japan’s diagnostic imaging system market will experience slow growth through 2034, driven by continuous technological advancement and rising hospital demand for efficient, patient-centric imaging…
Report
Biopsy Devices – Market Insights – Europe (Supplemental)
The European biopsy device market would be primarily driven by factors such as the expanding coverage for cancer screenings in the countries covered as well as updated recommendations to screening…
Report
Biopsy Devices – Market Insights – Europe
The European biopsy device market would be primarily driven by factors such as the expanding coverage for cancer screenings in the countries covered as well as updated recommendations to screening…
Report
Biopsy Devices – Market Insights – United States
The US biopsy device market has shown strong recovery from the impacts of the COVID-19 pandemic and is anticipated to resume prepandemic growth trends in the near term, with subsequent slow growth…